US FDA requests removal of suicide warnings from weight-loss drug labels
Jan 13 (Reuters) – The U.S. health regulator asked drugmakers on Tuesday to remove label warnings about a…
US FDA approves Vanda Pharmaceuticals’ motion sickness drug
Dec 30 (Reuters) – Vanda Pharmaceuticals (VNDA.O), opens new tab said on Tuesday its drug for the prevention…
FDA approves BioCryst’s oral pellet version of swelling disorder drug for children
Dec 12 (Reuters) – The U.S. Food and Drug Administration has approved an oral pellet formulation of BioCryst…
US FDA approves first at-home device for depression
Dec 11 (Reuters) – The U.S. Food and Drug Administration has approved Flow Neuroscience’s at-home brain stimulation device…
US FDA qualifies first AI tool to help speed liver disease drug development
Dec 8 (Reuters) – The U.S. Food and Drug Administration has qualified the first artificial intelligence tool designed…
AI’s rise stirs excitement, sparks job worries
AI’s impact on job growth and work transformation discussed at Reuters NEXT Concerns over AI’s role in job…
US slashes 36% off Medicare spending on 15 high-priced medicines
Medicare says negotiated prices for 15 drugs to cut spending by 36% New prices to take effect in…